(CW) Curtiss-Wright - Overview
Stock: Sensors, Valves, Pumps, Electronics, Actuators
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.20% |
| Yield on Cost 5y | 0.84% |
| Yield CAGR 5y | 6.98% |
| Payout Consistency | 90.7% |
| Payout Ratio | 9.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.5% |
| Relative Tail Risk | -5.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.92 |
| Alpha | 69.04 |
| Character TTM | |
|---|---|
| Beta | 1.062 |
| Beta Downside | 0.964 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.21% |
| CAGR/Max DD | 2.10 |
Description: CW Curtiss-Wright December 19, 2025
Curtiss-Wright Corp. (NYSE:CW) delivers engineered products and services across aerospace & defense, commercial power, process, and industrial markets through three operating segments: Aerospace & Industrial, Defense Electronics, and Naval & Power. The Aerospace & Industrial unit supplies power-management electronics, traction inverters, vehicle controls, aircraft sensors, and surface-technology services such as shot-peening and engineered coatings. Defense Electronics focuses on COTS embedded-computing modules, data-acquisition and flight-test gear, tactical communications, and weapons-handling systems. Naval & Power provides heavy-duty pumps, compact motors, generators, steam turbines, nuclear-reactor components, severe-service valves, and ship-repair services for the U.S. Navy.
Key quantitative touchpoints (FY 2023): revenue of roughly $2.5 billion, operating margin near 7 %, and a backlog of $1.1 billion, indicating a solid order pipeline. The segment’s performance is closely tied to two macro drivers: (1) sustained U.S. defense-spending growth-projected to rise ~3 % annually through 2028, bolstering demand for Defense Electronics and Naval & Power products; and (2) the global push for energy-efficient power-train technologies, which fuels demand for the company’s traction inverters and power-dense motors in both commercial and military vehicle platforms.
For a deeper dive into CW’s valuation metrics and scenario analysis, you might explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 465.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.40 > 1.0 |
| NWC/Revenue: 24.47% < 20% (prev 31.32%; Δ -6.85% < -1%) |
| CFO/TA 0.12 > 3% & CFO 592.0m > Net Income 465.1m |
| Net Debt (908.0m) to EBITDA (759.2m): 1.20 < 3 |
| Current Ratio: 1.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.8m) vs 12m ago -1.73% < -2% |
| Gross Margin: 37.43% > 18% (prev 0.37%; Δ 3706 % > 0.5%) |
| Asset Turnover: 67.60% > 50% (prev 63.10%; Δ 4.50% > 0%) |
| Interest Coverage Ratio: 14.92 > 6 (EBITDA TTM 759.2m / Interest Expense TTM 42.8m) |
Altman Z'' 6.25
| A: 0.16 (Total Current Assets 1.93b - Total Current Liabilities 1.10b) / Total Assets 5.10b |
| B: 0.82 (Retained Earnings 4.18b / Total Assets 5.10b) |
| C: 0.13 (EBIT TTM 639.0m / Avg Total Assets 4.99b) |
| D: 1.57 (Book Value of Equity 4.05b / Total Liabilities 2.57b) |
| Altman-Z'' Score: 6.25 = AAA |
Beneish M -2.94
| DSRI: 1.04 (Receivables 976.9m/857.6m, Revenue 3.38b/3.08b) |
| GMI: 0.99 (GM 37.43% / 37.01%) |
| AQI: 1.03 (AQ_t 0.51 / AQ_t-1 0.50) |
| SGI: 1.10 (Revenue 3.38b / 3.08b) |
| TATA: -0.02 (NI 465.1m - CFO 592.0m) / TA 5.10b) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of CW shares?
Over the past week, the price has changed by -1.12%, over one month by +9.46%, over three months by +12.79% and over the past year by +85.74%.
Is CW a buy, sell or hold?
- StrongBuy: 5
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 638.1 | -1.7% |
| Analysts Target Price | 638.1 | -1.7% |
| ValueRay Target Price | 1049.2 | 61.6% |
CW Fundamental Data Overview February 07, 2026
P/E Forward = 28.4091
P/S = 6.9045
P/B = 9.1102
P/EG = 2.71
Revenue TTM = 3.38b USD
EBIT TTM = 639.0m USD
EBITDA TTM = 759.2m USD
Long Term Debt = 968.6m USD (from longTermDebt, last quarter)
Short Term Debt = 119.8m USD (from shortTermDebt, last fiscal year)
Debt = 1.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 908.0m USD (from netDebt column, last quarter)
Enterprise Value = 24.22b USD (23.31b + Debt 1.13b - CCE 225.4m)
Interest Coverage Ratio = 14.92 (Ebit TTM 639.0m / Interest Expense TTM 42.8m)
EV/FCF = 46.87x (Enterprise Value 24.22b / FCF TTM 516.6m)
FCF Yield = 2.13% (FCF TTM 516.6m / Enterprise Value 24.22b)
FCF Margin = 15.30% (FCF TTM 516.6m / Revenue TTM 3.38b)
Net Margin = 13.78% (Net Income TTM 465.1m / Revenue TTM 3.38b)
Gross Margin = 37.43% ((Revenue TTM 3.38b - Cost of Revenue TTM 2.11b) / Revenue TTM)
Gross Margin QoQ = 37.68% (prev 37.21%)
Tobins Q-Ratio = 4.75 (Enterprise Value 24.22b / Total Assets 5.10b)
Interest Expense / Debt = 0.93% (Interest Expense 10.5m / Debt 1.13b)
Taxrate = 22.54% (36.3m / 161.2m)
NOPAT = 495.0m (EBIT 639.0m * (1 - 22.54%))
Current Ratio = 1.75 (Total Current Assets 1.93b / Total Current Liabilities 1.10b)
Debt / Equity = 0.45 (Debt 1.13b / totalStockholderEquity, last quarter 2.53b)
Debt / EBITDA = 1.20 (Net Debt 908.0m / EBITDA 759.2m)
Debt / FCF = 1.76 (Net Debt 908.0m / FCF TTM 516.6m)
Total Stockholder Equity = 2.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.31% (Net Income 465.1m / Total Assets 5.10b)
RoE = 18.15% (Net Income TTM 465.1m / Total Stockholder Equity 2.56b)
RoCE = 18.10% (EBIT 639.0m / Capital Employed (Equity 2.56b + L.T.Debt 968.6m))
RoIC = 13.96% (NOPAT 495.0m / Invested Capital 3.55b)
WACC = 9.41% (E(23.31b)/V(24.44b) * Re(9.83%) + D(1.13b)/V(24.44b) * Rd(0.93%) * (1-Tc(0.23)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.94%
[DCF Debug] Terminal Value 76.03% ; FCFF base≈500.0m ; Y1≈587.4m ; Y5≈894.0m
Fair Price DCF = 297.1 (EV 11.86b - Net Debt 908.0m = Equity 10.95b / Shares 36.9m; r=9.41% [WACC]; 5y FCF grow 18.63% → 2.90% )
EPS Correlation: 2.10 | EPS CAGR: -38.14% | SUE: -4.0 | # QB: 0
Revenue Correlation: 88.76 | Revenue CAGR: 7.33% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.98 | Chg30d=-0.020 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=14.61 | Chg30d=-0.089 | Revisions Net=-3 | Growth EPS=+11.3% | Growth Revenue=+7.3%